
Roche & Quest Establish Toeholds in Emerging Alzheimer’s Blood Testing Market
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.